SlideShare a Scribd company logo
1 of 88
What’s RED & HOT:
INFECTIONS in PREGNANCY
Helen Madamba, M.D. M.P.H.-T.M.
Mitzi Marie M. Chua, M.D.
http://www.epid.gov.lk/web/images/pdf/Influenza/Events/pregnant_women.gif
DISCLOSURES
Session
Objectives
To determine the optimum
treatment for selected infections
commonly seen in pregnancy
 UTI
 HIV/AIDS
 Hepatitis B infection
 Human papillomavirus
 Syphilis
To integrate a management
approach based on the current
evidence and local applicability
“InfectionPackage”
forPrenatalCare
Routine tests for infections
during prenatal care
 Urinalysis, urine culture for
UTI
 HIV Counselling and Testing
 HBsAg for Hepatitis B infection
 Papsmear for Human
papillomavirus
 RPR or VDRL for Syphilis
UrinaryTractInfection
(UTI)
Doyouroutinelyorderurine
cultureaspartofprenatalcare?
Question for our OBs in the audience
In ALL pregnant
patients, a urine
specimen should be
carefully collected for
urinalysis and
culturing during the
first prenatal visit or
at 12-16 weeks’ (9th-
17th, preferably 16th
week) gestation.
U.S. Preventive Services Task Force. Screening for asymptomatic bacteriuria in adults- U.S.
Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2008
Jul 1. 149(1)-43-7. [Medline].
Impactof
MaternalUTI
totheFetus
 Uterine hypoperfusion due to
maternal dehydration, maternal
anemia, and direct bacterial
endotoxin damage to the placental
vasculature  fetal cerebral
hypoperfusion
 Untreated upper UTIs associations:
 Low birth weight
 Prematurity; Premature labor
 Hypertension; preeclampsia
 Maternal anemia
 Amnionitis
UA–MSCC
 With one hand, spread the labia.
 With the other hand, use a castile soap–
moistened towelette to wipe the urethral
meatus downward toward the rectum,
then discard the towelette.
 Void the initial portion of the bladder
contents into the toilet.
 Catch the middle portion of the bladder
contents in the sterile collection
container, while keeping the labia spread
with the first hand.
RED-ytocollect?
UTI
Spectrum:
Acute cystitis
Asymptomatic bacteriuria (ASB)
Acute pyelonephritis
Management Pearls
Outpatient
Oral antibiotics
Inpatient, IV antibiotics
https://emedicine.medscape.com/article/452604-overview
Acute
Uncomplicated
Cystitis
A 27-year old, G1P0 13 weeks’
AOG, had urinary frequency and
terminal dysuria for 2 days. There
was no fever. There were also no
vaginal discharges.
WhatUTIcategory?
 A 27-year old, G1P0 13 weeks’ AOG, had
urinary frequency and terminal dysuria for 2
days. There was no fever. There were also
no vaginal discharges.
Diagnostics
 Urine culture/ sensitivity studies
 Significant pyuria (UA)
 >8 pus cells/mm3 of uncentrifuged urine, OR
 >5 pus cells/HPF of centrifuged urine
AND
 (+) leukocyte esterase and nitrite test on
dipstick
Strong recommendation, Moderate quality of evidence
✅
✅
✅
✅
✅
✅
✅
Asymptomatic
Bacteriuria
 A 37-year old G3P2 16 5/7 weeks AOG
had a urine culture growth of >100,000
CFU Escherichia coli.
 On review of presentation, patient had no
complaints but culture was ordered by
attending OB after 2 urinalysis samples
showed pyuria.
WhatUTIcategory?
✅
✅
✅
✅
✅
✅
Howwillyou
followupthis
pregnantpatient
withASB?
Post-treatment diagnostic tests
 A follow-up urine culture should be done
one week after completing the course of
treatment.
Weak recommendation, Low quality of evidence
Hot‘n
confusing?
ANTIBIOTIC SELECTION
 If the patient is clinically responding to the present
treatment, no need to revise the antibiotic if resistance
to the empirically started antibiotic is reported on
urine culture. Adjust antibiotic therapy based on urine
culture results ONLY when there is no improvement in
the clinical signs and symptoms and laboratory results
or when there is worsening of the patient’s condition.
Strong recommendation, Low quality of evidence
MONITORING
 Pregnant patients with pyelonephritis, recurrent UTIs,
concurrent gestational DM, concurrent nephrolithiasis
or urolithiasis, and pre- eclampsia, should be
monitored at monthly intervals until delivery to ensure
that urine remains sterile during pregnancy. Strong
recommendation, Low quality of evidence
[NAG] … and monitor every trimester till delivery.
SAFE
Firsttrimester
ofpregnancy
Amoxicillin-clavulanate
Cephalosporins
Fosfomycin
https://www.medscape.com/viewarticle/891799
Thisone’sHOT!
AVOID
Firsttrimester
ofpregnancy
Nitrofurantoin
Cotrimoxazole
https://www.medscape.com/viewarticle/891799
ThisisNOThot!
Acute
Uncomplicated
Pyelonephritis
A 30-year old, G2P1 12 weeks’
AOG, presented with fever and
chills. On PE, she had right
costovertebral angle tenderness.
WhatUTIcategory?
✅
✅
✅
✅
✅
✅
✅
✅
Renal
Ultrasound
Unless an anatomic abnormality or
renal disease is suspected, initial
routine imaging studies are not
necessary.
Patients with suspected
pyelonephritis who are not
responsive to appropriate antibiotic
therapy after 48-72 hours should
also undergo imaging.
Willyouorder?
Acute
Uncomplicated
Pyelonephritis
The same 30-year old, G2P1 now
30 weeks’ AOG, presented with
fever, no chills. On PE, she had
right costovertebral angle
tenderness.
Urine culture revealed ESBL
Escherichia coli.
Referred to ID; patient covered
with ertapenem
WhatUTIcategory?
Prevention
Behavioral
Methods
 Avoid baths.
 Wipe front-to-back after urinating or
defecating.
 Wash hands before using the toilet.
 Use washcloths to clean the perineum.
 Use liquid soap to prevent colonization
from bar soap.
 Clean the urethral meatus first when
bathing.
Thisone’sHOT!
HIV/AIDS
A21-yearold, G1P026weeksAOG,
(+)historyofIVdruguse,cameback
withCBC,U/A,andHBsAgresult.
HBsAgscreenisnon-reactive.
HIVscreenisreactive.
All pregnant patients routinely offered HIV testing.
https://www.hepmag.com/basics/hepatitis-b-
basics/pregnancy-hepatitis-b
 Prong 1. Primary prevention of HIV among
women of child-bearing age.
 Prong 2. Preventing unintended pregnancies
among women living with HIV.
 Prong 3. Preventing HIV transmission among
women living with HIV to her infant.
 Prong 4. Providing treatment, care and
support to women living with HIV, their
children and their families.
https://www.hsph.harvard.edu/population/aids/philippines.aids.09.pdf
Preventionof
Motherto Child
Transmissionof
HIVInfection
Prong1.Primaryprevention ofHIVamongwomenofchild-bearingage.
A – abstinence
B – be mutually faithful
C – check your status
D – don’t inject drugs
E – educate yourself and
others for early detection
Primary
Preventionof
HIVinfection
Prong2. PreventingunintendedpregnanciesamongwomenlivingwithHIV
Preventing
unplanned
pregnancies
HIV/AIDS and ART Registry of the Philippines, Department of Health Epidemiology Bureau
Prong3.PreventingHIVtransmissionamongwomenlivingwithHIVtoherinfant
Prenataland
Intrapartum
Care
PhilippineObstetricalandGynecologicalSociety(Foundation)Inc
ClinicalPracticeRecommendationonPreventionofMothertoChild
TransmissionofHIVInfection
HIV Screening
Antiretroviral Drugs
Management of Delivery
Infant Feeding
Contraception
POGS Clinical Practice Recommendations on PMTCT
Preliminary Counselling Dialogue
Providers of obstetric care should
inform the patient that an HIV
screening test will be performed as
part of the recommended routine
antenatal package of tests of
infections (HBsAg, RPR/VDRL,
papsmear, urine culture)
POGS Clinical Practice Recommendations on PMTCT
HIVCounselling
andTesting
Preliminary Counselling Dialogue
The fact that you are pregnant
is an evidence of unprotected
penetrative sexual contact
which is a mode of
transmission for HIV.
POGS Clinical Practice Recommendations on PMTCT
HIVCounselling
andTesting
AdvantagesofOptionB+
Earlier treatment for woman’s health
and avoiding risks of stopping and
starting triple ARVs especially in
settings of high fertility
Simple message to communities
“once ARV started, it is
taken for life.”
POGS Clinical Practice Recommendations on PMTCT
Anti-retroviral
(ARV)Drugs
• An elective cesarean
delivery is scheduled at 38
weeks AOG
• Emergency CS is done for
those in labor and with
ruptured membranes <4 hours
unless delivery is imminent
POGS Clinical Practice Recommendation on PMTCT of HIV Infection. November 2015.
Managementof
Delivery
Vaginal delivery maybe done
when the risk of maternal to child
transmission is low:
• those who had ARV treatment
• HIV viral load <1000 copies/ml
• if with ruptured membranes, the time
elapsed should be <4 hours to
delivery
POGS Clinical Practice Recommendation on PMTCT of HIV Infection. November 2015.
Managementof
Delivery
INFORMED
CONSENT
NO MIXED FEEDING
EXCLUSIVE breastfeeding
or
AFASS replacement feeding
InfantFeeding
REDHOTFEEDING!
initiate/continue ARV medications
replacement feeding: acceptable,
feasible, affordable, sustainable and
safe (AFASS)
risks, follow up and other options
for replacement feeding
relieve breast engorgement
POGS Clinical Practice Recommendations on PMTCT
InfantFeeding
REDHOTFEEDING!
A24-yearold, G7P7(7007) 3days
postpartum,breastfeedinginthe
ward. MHOcallstoinformthat
patientistheirprenatalclient.
HIVscreenisreactive.
REDHOTSURPRISE!
https://www.hepmag.com/basics/hepatitis-b-
basics/pregnancy-hepatitis-b
Continue exclusive breastfeeding
Initiate/continue ARV medications
for both mother and patient for as
long as breastfeeding up to two (2)
years
POGS Clinical Practice Recommendations on PMTCT
InfantFeeding
REDHOTFEEDING!
Prong4. Providingtreatment,care
andsupporttowomenlivingwithHIV,
theirchildrenandtheirfamilies.
Sexualand
reproductive
healthand
rights(SRHR)
Framework of WHO recommendations and good
practice statements to advance the sexual and
reproductive health and rights of women living
with HIV
Life goes on beyondHIV
Anti-retroviral
(ARV)Drugs
HepatitisBin
Pregnancy
A19-year old, G1P016weeks
pregnant, camebackwithCBC,
U/A,and HBsAgresult.
HBsAgscreenisreactive.
HBs Ag screen seems always done.
https://www.hepmag.com/basics/hepatitis-b-
basics/pregnancy-hepatitis-b
Whatdoyou
do?
Additional testing (ALT, HBV
DNA, or imaging for HCC
surveillance if indicated)
Determination of need for antiviral
therapy
Women who meet standard
indications for HBV therapy should
be treated.
Getaviralload!
Pregnant women positive for
HBsAg should be tested for hep B
virus deoxyribonucleic acid (HBV
DNA) to guide the use of antiviral
medication to prevent perinatal
transmission.
Red-hotCOST!
Individualize
therapytoreduce
theriskof
perinatal
transmission.
The American Association for the
Study of Liver Diseases (AASLD)
suggests antiviral therapy for
pregnant women with HBV DNA
>200,000 IU/mL.
Quality and Certainty of Evidence: Low
Strength of Recommendation: Conditional
Theironyof“strengthof
recommendation”
AASLD recommends against the
use of antiviral therapy to reduce
the risk of perinatal transmission
of HBV in HBsAg-positive
pregnant women with an HBV-
DNA level <200,000 IU/mL.
Quality and Certainty of Evidence: Low
Strength of Recommendation: Strong
Whatto
give?
The only antivirals studied in
pregnant women are lamivudine,
telbivudine, and tenofovir (TDF).
TDF preferred to minimize the risk
of emergence of viral resistance
during treatment
Red-hotchoices
Timing&
Duration
Antiviral therapy started at 28-32
weeks’ gestation in most studies.
Discontinued at time of delivery or
up to 4 weeks postpartum
 At time of birth to 3 months
postpartum in most studies
With discontinuation of treatment,
women should be monitored closely
for up to 6 months after delivery for
hepatitis flares & seroconversion.
Immune-active
hepatitis
 Elevation of ALT >2 the ULN or evidence of
significant histologic disease
 ULN for ALT in healthy adults is reported to be
29-33 U/L for males and 19-25 U/L for females. A
ULN for ALT of 35 U/L for males and 25 U/L for
females is recommended to guide management
decisions.
PLUS
 Elevated HBV DNA above 2,000 IU/mL
(HBeAg negative) or above 20,000 IU/mL
(HBeAg positive).
 Treatment should be based on
recommendations for nonpregnant women.
Butdonotethat–
Breastfeeding
NOT contraindicated
Antivirals minimally excreted in
breast milk &unlikely to cause
significant toxicity
Insufficient long-term safety data
in infants born to mothers who
took antiviral agents during
pregnancy and while breastfeeding
HotOtherMatters
Wedon’tmiss
this,dowe?
The CDC continues to recommend
hepatitis B vaccination and
hepatitis immune globulin
regardless of birth weight within
12 hours of birth for infants born to
hepatitis B-infected mothers.
Red-hotINTERVENTION
Doyouroutinelyvaccinate
pregnantwomenaspartof
prenatalcare?
Question for our OBs in the audience
• Tetanus-
diphtheria-
pertussis
• Influenza vaccine
• Pneumococcal
vaccine
• Hepatitis B
POGS Clinical Practice Guidelines on Immunization for Filipino Women 2011
Whichvaccinesare
contraindicatedinpregnancy?
Live attenuated
vaccines are
contraindicated
in pregnancy.
• HPV vaccine
• Varicella zoster
• Measles, mumps
and rubella
POGS Clinical Practice Guidelines on Immunization for Filipino Women 2011
Tetanus-diphtheria-pertussis
(Tdap)vaccine
No previous tetanus
immunization of
unknown status:
• 3 doses of Td
vaccine given one
month apart,
starting second
trimester
• 3rd dose given
postpartum as
Tdap
Level 1 Grade A
POGS Clinical Practice Guidelines on Immunization for Filipino Women 2011
Tetanus-diphtheria-pertussis
(Tdap)vaccine
Last Td/Tdap
vaccination more
than 10 years ago:
• Td booster in
second or 3rd
trimester of
pregnancy
Level 1 Grade A
POGS Clinical Practice Guidelines on Immunization for Filipino Women 2011
Influenzavaccine
All pregnant and
breastfeeding
women should
receive the
inactivated flu
vaccine
(Level I, Grade A)
POGS Clinical Practice Guidelines on Immunization for Filipino Women 2011
Pneumococcalvaccine
Pneumococcal
vaccination should be
recommended to
pregnant and
breastfeeding women
who are at high-risk
for invasive
pneumococcal disease.
POGS Clinical Practice Guidelines on Immunization for Filipino Women 2011
Pneumococcalvaccine
Pneumococcal
vaccination should
preferably be
administered during
the 2nd or 3rd trimester
of pregnancy as a
general safety
precaution.
POGS Clinical Practice Guidelines on Immunization for Filipino Women 2011
HepatitisBvaccine
• Hepatitis B vaccine
may be administered
to a pregnant women
who is otherwise
eligible for it.
• HBsAg-negative
pregnant women not
previously
vaccinated
POGS Clinical Practice Guidelines on Immunization for Filipino Women 2011
HumanPapillomavirus
(HPV)
HPV screening
 In 2003, the FDA approved a screening test that
can be done in conjunction with a Pap test to
determine if you have the HPV virus. The HPV
DNA test can detect high risk types of HPV, such
as types 16 and 18, before any abnormal cells can
be detected on the cervix.
 This screening is recommended for women over
the age of 30, who are at an increased risk of a
chronic HPV infection turning into pre-cancerous
cells.
 Men can carry and transmit the HPV infection
without ever having symptoms. At this time,
there is no test to detect HPV in men.
36year oldelderly primigravid
consults forprenatal checkup
complaining ofcauliflower-like
massesonthevulva.
HPV causes genital warts.
https://www.hepmag.com/basics/hepatitis-b-
basics/pregnancy-hepatitis-b
HPV Infection
~100 types of HPV
infection, 40 can infect
genital area
Most sexually active
persons become infected
with HPV at leat once in
their lifetime.
Red-hotMYSTERIES
HPV Infection
Oncogenic, high-risk HPV
infection causes most cervical,
penile, vulvar, vaginal, anal
and oropharyngeal cancers
and pre-cancers
Non-oncogenic low-risk HPV
infection causes genital warts
and recurrent respiratory
papillomatosis
Red-hotMYSTERIES
CDC Sexually Transmitted Diseases Guidelines, 2015
KeyMessages
forCounselling
Most sexually active people get
HPV at some time in their lives,
although most never know it.
It is not possible to determine
which partner transmitted the
original infection.
Types of HPV that cause genital
warts are different from the types
that cause cancer.
Red-hotMESSAGES
CDC Sexually Transmitted Diseases Guidelines, 2015
Special
Considerations
Podofilox, podophyllin,
sinecatechins, imiquimod should
not be used in pregnancy
Anogenital warts can proliferate
and become friable during
pregnancy
Resolution might be incomplete or
poor until pregnancy is complete.
Red-hotMESSAGES
CDC Sexually Transmitted Diseases Guidelines, 2015
Managementof
Delivery
Cesarean delivery should not be
performed solely to prevent
transmission of HPV infection to
the newborn
Cesarean delivery is indicated if
pelvic outlet is obstructed or if
vaginal delivery would result in
excessive bleeding.
Low risk for recurrent respiratory
papillomatosis
CDC Sexually Transmitted Diseases Guidelines, 2015
Doyouroutinelyscreenfor
HPVaspartofprenatalcare?
Question for our OBs in the audience
Cervical cancer
screening should be
part of routine
prenatal care.
• Papsmear
• Visual inspection
with acetic acid
(VIA)
• HPV testing
Society of Gynecologic Oncologists of the Philippines (Foundation) Inc.
Clinical Practice Guidelines for the Obstetrician-Gynecologist 2010
Doyouroutinelyscreenfor
HPVaspartofprenatalcare?
Question for our OBs in the audience
Cervical cancer
screening should be
part of routine
prenatal care.
• Papsmear
• Visual inspection
with acetic acid
(VIA)
• HPV testing
Society of Gynecologic Oncologists of the Philippines (Foundation) Inc.
Clinical Practice Guidelines for the Obstetrician-Gynecologist 2010
AmIatriskfor
cervicalcancer?
 HPV infection is the necessary cause of
cervical cancer.
 Parity of 7 or more
 Long-term use of OCPs
 Smoking
 Co-infection of HPV with Chlamydia
trachomatis or herpes simplex virus
 HIV infection
REDflags-risks
Society of Gynecologic Oncologists of the Philippines (Foundation) Inc.
Clinical Practice Guidelines for the Obstetrician-Gynecologist 2010
AmIatriskfor
cervicalcancer?
 Early age at first intercourse
 Lifetime number of sexual partners
 Early age at first full term pregnancy
 Uncircumcised male partner
 No prior screening
 Low socioeconomic status
REDflags-risks
Society of Gynecologic Oncologists of the Philippines (Foundation) Inc.
Clinical Practice Guidelines for the Obstetrician-Gynecologist 2010
Primary
Preventionof
cervicalcancer
 Total abstinence prevents HPV infection.
 Lifetime mutual monogamy prevents
HPV infection.
 Consistent and correct use of barrier
protection decreases cervical cancer
incidence.
 Vaccination against HPV 16/18 is
efficacious against persistent HPV
infection and ≥ CIN 2+.
REDHOTINTERVENTION
Society of Gynecologic Oncologists of the Philippines (Foundation) Inc.
Clinical Practice Guidelines for the Obstetrician-Gynecologist 2010
Secondary
Preventionof
cervicalcancer
 Regular gynecologic examinations and
cytologic test (Pap smear) with treatment
of precancerous abnormalities
 Liquid based cytology
 Visual inspection with acetic acid is an
acceptable alternative to Pap smear.
REDHOTINTERVENTION
Society of Gynecologic Oncologists of the Philippines (Foundation) Inc.
Clinical Practice Guidelines for the Obstetrician-Gynecologist 2010
Secondary
Preventionof
cervicalcancer
 Screening should begin approximately 3
years after onset of vaginal intercourse
but not earlier than 21.
 Annual screening with conventional
cervical cytology until age 30 years.
 At or after age 30 years, a woman who
has had 3 consecutive normal results
may undergo screening ever 2 to 3 years
REDHOTINTERVENTION
Society of Gynecologic Oncologists of the Philippines (Foundation) Inc.
Clinical Practice Guidelines for the Obstetrician-Gynecologist 2010
Secondary
Preventionof
cervicalcancer
 Annual gynecologic examination is
recommended regardless of the frequency
of screening.
 Women immunized against HPV 16/18
should be screened same as non-
immunized women.
 A pap test should be obtained twice in
the first year after diagnosis of HIV
infection and if results are normal,
annually thereafter.
REDHOTINTERVENTION
Society of Gynecologic Oncologists of the Philippines (Foundation) Inc.
Clinical Practice Guidelines for the Obstetrician-Gynecologist 2010
 In 2003, the FDA approved a screening test that can be
done in conjunction with a Pap test to determine if you
have the HPV virus. The HPV DNA test can detect
high risk types of HPV, such as types 16 and 18, before
any abnormal cells can be detected on the cervix.
 This screening is recommended for women over the age
of 30, who are at an increased risk of a chronic HPV
infection turning into pre-cancerous cells.
 Men can carry and transmit the HPV infection without
ever having symptoms. At this time, there is no test to
detect HPV in men.
SYPHILIS
Doyouroutinelyordersyphilis
screenaspartofprenatalcare?
Question for our OBs in the audience
All pregnant
women should be
screened for
syphilis early in
pregnancy.
CDC Sexually Transmitted Diseases Guidelines, 2015
20year oldG2P1
complained of
vulvar ulcers
RPRreactive
TPPApositive
Syphilis
Infection
Primary syphilis infection – ulcers or
chancre at the infection site
Secondary syphilis – skin rash,
mucocutaneous lesions,
lymphadenopathy
Tertiary syphilis – cardiac,
gummatous lesions, tabes dorsalis,
general paresis
Latent syphilis infection – those
lacking manifestations, detected by
serologic testing
 Early latent syphilis – acquired within the preceding year
 Late latent syphilis – acquired more than a year prior
 Syphilis of unknown duration
DiagnosticTests
forSyphilis
Darkfield examination from lesion
exudates  definitive method for
diagnosing Treponema pallidum
A presumptive diagnosis of
syphilis requires use of two tests:
Nontreponemal test like VDRL
or RPR
Treponemal test like FTA-ABS,
TP-PA, TP-EIA or rapid
treponemal assays
SyphilisScreening
• For patients with poor prenatal care, RPR test screening and treatment should
be performed at the time pregnancy is confirmed
• Pregnant women with reactive treponemal screening tests should have
additional quantitative nontreponemal testing to monitor treatment response.
• For women at high risk of infection, serologic testing should be performed
twice, at 28-32 weeks AOG and at delivery
• Any woman with fetal death after 20 weeks AOG should be tested for syphilis.
Syphilisduring
Pregnancy
Risk for antepartum fetal infection or
congenital syphilis at delivery is
related to the stage of syphilis during
pregnancy, with the highest risk
occurring with the primary and
secondary stage.
Quantitative maternal nontreponemal
titer, especially if >1:8, might be a
marker of early infection and
bacteremia.
SyphilisScreening
•If a treponemal test (e.g., EIA or CIA) is used for antepartum
syphilis screening, all positive EIA/CIA tests should be reflexed to
a quantitative nontreponemal test (RPR or VDRL).
•If the nontreponemal test is negative, then the results are
considered discrepant and a second treponemal test (TP-PA
preferred) should be performed, preferably on the same specimen.
•If the second treponemal test is positive, current or past syphilis
infection can be confirmed.
SyphilisScreening
•If the second treponemal test is negative, the positive EIA/CIA is
more likely to represent a false-positive test result in low-risk
women with no history of treated syphilis.
•If the woman is at low risk for syphilis, (-) signs or symptoms,
partner (-) syphilis, and is likely to follow up, repeat serologic testing
within 4 weeks.
•If both the RPR and TP-PA remain negative, no further treatment is
necessary.
•If follow-up is not possible, women without a history of treated
syphilis should be treated according to the stage of syphilis.
Preferred
Regimen
Penicillin is the only drug
recommended for treatment of
pregnant women with syphilis.
 Pregnant women allergic to penicillin should be desensitized and treated with
penicillin.
 Primary, Secondary, Early Latent (<1 year
duration)
 1st line: Benzathine penicillin G 2.4MU IM
x 1 dose
 Late latent (including unknown duration)
 1st line: Benzathine penicillin G 7.2 MU
total, administered as 3 doses of 2.4 MU IM
each buttock at 1-week intervals
Management
Pearls
 When syphilis is diagnosed during the second
half of pregnancy
 Include a sonographic fetal evaluation for
congenital syphilis
 Sonographic signs of fetal or placental syphilis
(i.e., hepatomegaly, ascites, hydrops, fetal anemia,
or a thickened placenta) indicate a greater risk for
fetal treatment failure
 Women treated for syphilis during the second half
of pregnancy are at risk for premature labor
and/or fetal distress if the treatment precipitates
the Jarisch-Herxheimer reaction.
 Advise to seek obstetric attention after treatment
if they notice any fever, contractions, or decrease
in fetal movements.
Missed doses are not acceptable for
pregnant women receiving therapy
for late latent syphilis. Pregnant
women who miss any dose of
therapy must repeat the full course
of therapy.
All women who have syphilis
should be offered testing for HIV
infection.
Management
Pearls
SYNTHESIS

More Related Content

What's hot

DRUGS IN PREGNANCY
 				DRUGS IN PREGNANCY 				DRUGS IN PREGNANCY
DRUGS IN PREGNANCYgolden4host
 
Drugs used in pregnancy
Drugs used in pregnancyDrugs used in pregnancy
Drugs used in pregnancyethan1hunt
 
Drug therapy during_pregnancy (1)
Drug therapy during_pregnancy (1)Drug therapy during_pregnancy (1)
Drug therapy during_pregnancy (1)Amira Badr
 
Swine flu in pregnancy
Swine flu in pregnancySwine flu in pregnancy
Swine flu in pregnancydr.hafsa asim
 
Drug therapy in Pregnancy
Drug therapy in PregnancyDrug therapy in Pregnancy
Drug therapy in PregnancyDr Manju prasad
 
Selective progesteron reuptake modualtors
Selective progesteron reuptake modualtorsSelective progesteron reuptake modualtors
Selective progesteron reuptake modualtorsDr. Rupendra Bharti
 
Antibiotics during pregnancy
Antibiotics during  pregnancyAntibiotics during  pregnancy
Antibiotics during pregnancyKalkidan Gulilat
 
POST DATED PREGNANCY AND INTRA-UTERINE FETAL DEATH, IUFD, Mob: 7289915430, w...
POST DATED PREGNANCY AND INTRA-UTERINE FETAL DEATH, IUFD,  Mob: 7289915430, w...POST DATED PREGNANCY AND INTRA-UTERINE FETAL DEATH, IUFD,  Mob: 7289915430, w...
POST DATED PREGNANCY AND INTRA-UTERINE FETAL DEATH, IUFD, Mob: 7289915430, w...Pradeep Garg
 
Thromboprophylaxis in Obstetrics
Thromboprophylaxis in ObstetricsThromboprophylaxis in Obstetrics
Thromboprophylaxis in ObstetricsSujoy Dasgupta
 
ATOSIBAN a New Hope in Preterm Labour Dr. Sharda jain
ATOSIBAN a New Hope in Preterm Labour Dr. Sharda jain ATOSIBAN a New Hope in Preterm Labour Dr. Sharda jain
ATOSIBAN a New Hope in Preterm Labour Dr. Sharda jain DGFPublicAwareness
 
Epilepsy in pregnancy
Epilepsy in pregnancy Epilepsy in pregnancy
Epilepsy in pregnancy DR MUKESH SAH
 
Preconception care: Aboubakr Elnashar
Preconception care: Aboubakr ElnasharPreconception care: Aboubakr Elnashar
Preconception care: Aboubakr ElnasharAboubakr Elnashar
 
HORMONAL CONTRACEPTION & NEWER CONTRACEPTIVES BY DR SHASHWAT JANI
HORMONAL CONTRACEPTION & NEWER CONTRACEPTIVES BY DR SHASHWAT JANIHORMONAL CONTRACEPTION & NEWER CONTRACEPTIVES BY DR SHASHWAT JANI
HORMONAL CONTRACEPTION & NEWER CONTRACEPTIVES BY DR SHASHWAT JANIDR SHASHWAT JANI
 

What's hot (20)

DRUGS IN PREGNANCY
 				DRUGS IN PREGNANCY 				DRUGS IN PREGNANCY
DRUGS IN PREGNANCY
 
Drugs and pregnancy
Drugs and pregnancyDrugs and pregnancy
Drugs and pregnancy
 
Drugs used in pregnancy
Drugs used in pregnancyDrugs used in pregnancy
Drugs used in pregnancy
 
Drug use in pregnany
Drug use in pregnanyDrug use in pregnany
Drug use in pregnany
 
Drug therapy during_pregnancy (1)
Drug therapy during_pregnancy (1)Drug therapy during_pregnancy (1)
Drug therapy during_pregnancy (1)
 
Swine flu in pregnancy
Swine flu in pregnancySwine flu in pregnancy
Swine flu in pregnancy
 
Drug therapy in Pregnancy
Drug therapy in PregnancyDrug therapy in Pregnancy
Drug therapy in Pregnancy
 
Selective progesteron reuptake modualtors
Selective progesteron reuptake modualtorsSelective progesteron reuptake modualtors
Selective progesteron reuptake modualtors
 
Antibiotics during pregnancy
Antibiotics during  pregnancyAntibiotics during  pregnancy
Antibiotics during pregnancy
 
Contraception
ContraceptionContraception
Contraception
 
Carbetocin in PPH
Carbetocin in PPHCarbetocin in PPH
Carbetocin in PPH
 
Combined oral contraceptive pills
Combined oral contraceptive pillsCombined oral contraceptive pills
Combined oral contraceptive pills
 
POST DATED PREGNANCY AND INTRA-UTERINE FETAL DEATH, IUFD, Mob: 7289915430, w...
POST DATED PREGNANCY AND INTRA-UTERINE FETAL DEATH, IUFD,  Mob: 7289915430, w...POST DATED PREGNANCY AND INTRA-UTERINE FETAL DEATH, IUFD,  Mob: 7289915430, w...
POST DATED PREGNANCY AND INTRA-UTERINE FETAL DEATH, IUFD, Mob: 7289915430, w...
 
Preterm labour
Preterm labourPreterm labour
Preterm labour
 
Thromboprophylaxis in Obstetrics
Thromboprophylaxis in ObstetricsThromboprophylaxis in Obstetrics
Thromboprophylaxis in Obstetrics
 
Infections in pregnancy 1 3 15
Infections in pregnancy 1 3 15Infections in pregnancy 1 3 15
Infections in pregnancy 1 3 15
 
ATOSIBAN a New Hope in Preterm Labour Dr. Sharda jain
ATOSIBAN a New Hope in Preterm Labour Dr. Sharda jain ATOSIBAN a New Hope in Preterm Labour Dr. Sharda jain
ATOSIBAN a New Hope in Preterm Labour Dr. Sharda jain
 
Epilepsy in pregnancy
Epilepsy in pregnancy Epilepsy in pregnancy
Epilepsy in pregnancy
 
Preconception care: Aboubakr Elnashar
Preconception care: Aboubakr ElnasharPreconception care: Aboubakr Elnashar
Preconception care: Aboubakr Elnashar
 
HORMONAL CONTRACEPTION & NEWER CONTRACEPTIVES BY DR SHASHWAT JANI
HORMONAL CONTRACEPTION & NEWER CONTRACEPTIVES BY DR SHASHWAT JANIHORMONAL CONTRACEPTION & NEWER CONTRACEPTIVES BY DR SHASHWAT JANI
HORMONAL CONTRACEPTION & NEWER CONTRACEPTIVES BY DR SHASHWAT JANI
 

Similar to Red Hot Infections in Pregnancy

PELVIC INFLAMMATORY DISEASE (PID)
PELVIC INFLAMMATORY DISEASE (PID)PELVIC INFLAMMATORY DISEASE (PID)
PELVIC INFLAMMATORY DISEASE (PID)Dawood Al nasser
 
Updates in Viral STIs in Pregnancy
Updates in Viral STIs in PregnancyUpdates in Viral STIs in Pregnancy
Updates in Viral STIs in PregnancyHelen Madamba
 
Urinary tract infection in children
Urinary tract infection in childrenUrinary tract infection in children
Urinary tract infection in childrenEashaKiani1
 
A case of acute Pelvic Inflammatory Disease (PID)
A case of acute Pelvic Inflammatory Disease (PID)A case of acute Pelvic Inflammatory Disease (PID)
A case of acute Pelvic Inflammatory Disease (PID)Dr.Emmanuel Godwin
 
Acute pelvic inflammatory disease by dr alka mukherjee dr apurva mukherjee
Acute pelvic inflammatory disease by dr alka mukherjee dr apurva mukherjeeAcute pelvic inflammatory disease by dr alka mukherjee dr apurva mukherjee
Acute pelvic inflammatory disease by dr alka mukherjee dr apurva mukherjeealka mukherjee
 
Antenatal care.pptx
Antenatal care.pptxAntenatal care.pptx
Antenatal care.pptx9459654457
 
Management of hepatitis c in pregnancy
Management of hepatitis c in pregnancyManagement of hepatitis c in pregnancy
Management of hepatitis c in pregnancyBasem Hamed
 
Hiv infection in pregnancy
Hiv infection in pregnancyHiv infection in pregnancy
Hiv infection in pregnancyMpPm4
 
seminar on urinary tract infection
seminar on urinary tract infectionseminar on urinary tract infection
seminar on urinary tract infectionDr. Habibur Rahim
 
ASB-UTI-slides.pptx
ASB-UTI-slides.pptxASB-UTI-slides.pptx
ASB-UTI-slides.pptxAayAn40
 
case study on incomplete abortion.docx
case study on incomplete abortion.docxcase study on incomplete abortion.docx
case study on incomplete abortion.docxRajani17
 
pap smear and pelvic examination presentation
pap smear and pelvic examination presentationpap smear and pelvic examination presentation
pap smear and pelvic examination presentationshahedshaderma15
 

Similar to Red Hot Infections in Pregnancy (20)

PELVIC INFLAMMATORY DISEASE (PID)
PELVIC INFLAMMATORY DISEASE (PID)PELVIC INFLAMMATORY DISEASE (PID)
PELVIC INFLAMMATORY DISEASE (PID)
 
Updates in Viral STIs in Pregnancy
Updates in Viral STIs in PregnancyUpdates in Viral STIs in Pregnancy
Updates in Viral STIs in Pregnancy
 
Hiv krt
Hiv krtHiv krt
Hiv krt
 
HIV IN PREGNANCY
HIV IN PREGNANCYHIV IN PREGNANCY
HIV IN PREGNANCY
 
Septic abortion
Septic abortionSeptic abortion
Septic abortion
 
Ectopic pregnancy
Ectopic pregnancyEctopic pregnancy
Ectopic pregnancy
 
Pid by dr naz pptx
Pid  by dr naz pptxPid  by dr naz pptx
Pid by dr naz pptx
 
Urinary tract infection in children
Urinary tract infection in childrenUrinary tract infection in children
Urinary tract infection in children
 
A case of acute Pelvic Inflammatory Disease (PID)
A case of acute Pelvic Inflammatory Disease (PID)A case of acute Pelvic Inflammatory Disease (PID)
A case of acute Pelvic Inflammatory Disease (PID)
 
pid.pptx
pid.pptxpid.pptx
pid.pptx
 
Acute pelvic inflammatory disease by dr alka mukherjee dr apurva mukherjee
Acute pelvic inflammatory disease by dr alka mukherjee dr apurva mukherjeeAcute pelvic inflammatory disease by dr alka mukherjee dr apurva mukherjee
Acute pelvic inflammatory disease by dr alka mukherjee dr apurva mukherjee
 
Antenatal care.pptx
Antenatal care.pptxAntenatal care.pptx
Antenatal care.pptx
 
Management of hepatitis c in pregnancy
Management of hepatitis c in pregnancyManagement of hepatitis c in pregnancy
Management of hepatitis c in pregnancy
 
Hiv infection in pregnancy
Hiv infection in pregnancyHiv infection in pregnancy
Hiv infection in pregnancy
 
seminar on urinary tract infection
seminar on urinary tract infectionseminar on urinary tract infection
seminar on urinary tract infection
 
ASB-UTI-slides.pptx
ASB-UTI-slides.pptxASB-UTI-slides.pptx
ASB-UTI-slides.pptx
 
case study on incomplete abortion.docx
case study on incomplete abortion.docxcase study on incomplete abortion.docx
case study on incomplete abortion.docx
 
Antenatal care
Antenatal careAntenatal care
Antenatal care
 
pap smear and pelvic examination presentation
pap smear and pelvic examination presentationpap smear and pelvic examination presentation
pap smear and pelvic examination presentation
 
HIV in pregnancy
HIV in pregnancyHIV in pregnancy
HIV in pregnancy
 

More from Helen Madamba

Cultivating Early Career Researchers on Doing Health Research for Policy Deve...
Cultivating Early Career Researchers on Doing Health Research for Policy Deve...Cultivating Early Career Researchers on Doing Health Research for Policy Deve...
Cultivating Early Career Researchers on Doing Health Research for Policy Deve...Helen Madamba
 
The Role of Maternal Immunization in Reducing Infections in Infants
The Role of Maternal Immunization in Reducing Infections in InfantsThe Role of Maternal Immunization in Reducing Infections in Infants
The Role of Maternal Immunization in Reducing Infections in InfantsHelen Madamba
 
HEALTH EDUCATION THROUGH MEDIA
HEALTH EDUCATION THROUGH MEDIAHEALTH EDUCATION THROUGH MEDIA
HEALTH EDUCATION THROUGH MEDIAHelen Madamba
 
COVID-19 and COVID-19 Vaccination in Pregnancy
COVID-19 and COVID-19 Vaccination in PregnancyCOVID-19 and COVID-19 Vaccination in Pregnancy
COVID-19 and COVID-19 Vaccination in PregnancyHelen Madamba
 
Surviving Sepsis in Pregnancy
Surviving Sepsis in PregnancySurviving Sepsis in Pregnancy
Surviving Sepsis in PregnancyHelen Madamba
 
Use of Social Media in Medicine
Use of Social Media in MedicineUse of Social Media in Medicine
Use of Social Media in MedicineHelen Madamba
 
Use of social media for public health promotion
Use of social media for public health promotionUse of social media for public health promotion
Use of social media for public health promotionHelen Madamba
 
HIV 101 Facilitation Skills
HIV 101 Facilitation SkillsHIV 101 Facilitation Skills
HIV 101 Facilitation SkillsHelen Madamba
 
HIV Updates and Controversies
HIV Updates and ControversiesHIV Updates and Controversies
HIV Updates and ControversiesHelen Madamba
 
Choosing Platforms for Social Media
Choosing Platforms for Social MediaChoosing Platforms for Social Media
Choosing Platforms for Social MediaHelen Madamba
 
Social Dimensions of HIV and STIs
Social Dimensions of HIV and STIsSocial Dimensions of HIV and STIs
Social Dimensions of HIV and STIsHelen Madamba
 
Emerging Issues for Social Workers in dealing with PLHIVs
Emerging Issues for Social Workers in dealing with PLHIVsEmerging Issues for Social Workers in dealing with PLHIVs
Emerging Issues for Social Workers in dealing with PLHIVsHelen Madamba
 
POGS Research Workshop 2019
POGS Research Workshop 2019POGS Research Workshop 2019
POGS Research Workshop 2019Helen Madamba
 
Surgical Site Infections
Surgical Site InfectionsSurgical Site Infections
Surgical Site InfectionsHelen Madamba
 
Public Health Forum - Social Media in Medicine: Etiquettes for the Modern Doctor
Public Health Forum - Social Media in Medicine: Etiquettes for the Modern DoctorPublic Health Forum - Social Media in Medicine: Etiquettes for the Modern Doctor
Public Health Forum - Social Media in Medicine: Etiquettes for the Modern DoctorHelen Madamba
 
#BoholHIVAIDSSummit2018 PMTCT of HIV Infection
#BoholHIVAIDSSummit2018 PMTCT of HIV Infection#BoholHIVAIDSSummit2018 PMTCT of HIV Infection
#BoholHIVAIDSSummit2018 PMTCT of HIV InfectionHelen Madamba
 

More from Helen Madamba (20)

Cultivating Early Career Researchers on Doing Health Research for Policy Deve...
Cultivating Early Career Researchers on Doing Health Research for Policy Deve...Cultivating Early Career Researchers on Doing Health Research for Policy Deve...
Cultivating Early Career Researchers on Doing Health Research for Policy Deve...
 
The Role of Maternal Immunization in Reducing Infections in Infants
The Role of Maternal Immunization in Reducing Infections in InfantsThe Role of Maternal Immunization in Reducing Infections in Infants
The Role of Maternal Immunization in Reducing Infections in Infants
 
HEALTH EDUCATION THROUGH MEDIA
HEALTH EDUCATION THROUGH MEDIAHEALTH EDUCATION THROUGH MEDIA
HEALTH EDUCATION THROUGH MEDIA
 
COVID-19 and COVID-19 Vaccination in Pregnancy
COVID-19 and COVID-19 Vaccination in PregnancyCOVID-19 and COVID-19 Vaccination in Pregnancy
COVID-19 and COVID-19 Vaccination in Pregnancy
 
Surviving Sepsis in Pregnancy
Surviving Sepsis in PregnancySurviving Sepsis in Pregnancy
Surviving Sepsis in Pregnancy
 
COVID IN PREGNANCY
COVID IN PREGNANCYCOVID IN PREGNANCY
COVID IN PREGNANCY
 
HIV in PREGNANCY
HIV in PREGNANCYHIV in PREGNANCY
HIV in PREGNANCY
 
Use of Social Media in Medicine
Use of Social Media in MedicineUse of Social Media in Medicine
Use of Social Media in Medicine
 
Use of social media for public health promotion
Use of social media for public health promotionUse of social media for public health promotion
Use of social media for public health promotion
 
HIV 101 Facilitation Skills
HIV 101 Facilitation SkillsHIV 101 Facilitation Skills
HIV 101 Facilitation Skills
 
HIV Updates and Controversies
HIV Updates and ControversiesHIV Updates and Controversies
HIV Updates and Controversies
 
Choosing Platforms for Social Media
Choosing Platforms for Social MediaChoosing Platforms for Social Media
Choosing Platforms for Social Media
 
Research Ethics
Research EthicsResearch Ethics
Research Ethics
 
Social Dimensions of HIV and STIs
Social Dimensions of HIV and STIsSocial Dimensions of HIV and STIs
Social Dimensions of HIV and STIs
 
Emerging Issues for Social Workers in dealing with PLHIVs
Emerging Issues for Social Workers in dealing with PLHIVsEmerging Issues for Social Workers in dealing with PLHIVs
Emerging Issues for Social Workers in dealing with PLHIVs
 
POGS Research Workshop 2019
POGS Research Workshop 2019POGS Research Workshop 2019
POGS Research Workshop 2019
 
TAYTAYAN AMSA-SOMA
TAYTAYAN AMSA-SOMATAYTAYAN AMSA-SOMA
TAYTAYAN AMSA-SOMA
 
Surgical Site Infections
Surgical Site InfectionsSurgical Site Infections
Surgical Site Infections
 
Public Health Forum - Social Media in Medicine: Etiquettes for the Modern Doctor
Public Health Forum - Social Media in Medicine: Etiquettes for the Modern DoctorPublic Health Forum - Social Media in Medicine: Etiquettes for the Modern Doctor
Public Health Forum - Social Media in Medicine: Etiquettes for the Modern Doctor
 
#BoholHIVAIDSSummit2018 PMTCT of HIV Infection
#BoholHIVAIDSSummit2018 PMTCT of HIV Infection#BoholHIVAIDSSummit2018 PMTCT of HIV Infection
#BoholHIVAIDSSummit2018 PMTCT of HIV Infection
 

Recently uploaded

Leading transformational change: inner and outer skills
Leading transformational change: inner and outer skillsLeading transformational change: inner and outer skills
Leading transformational change: inner and outer skillsHelenBevan4
 
hyderabad call girl.pdfRussian Call Girls in Hyderabad Amrita 9907093804 Inde...
hyderabad call girl.pdfRussian Call Girls in Hyderabad Amrita 9907093804 Inde...hyderabad call girl.pdfRussian Call Girls in Hyderabad Amrita 9907093804 Inde...
hyderabad call girl.pdfRussian Call Girls in Hyderabad Amrita 9907093804 Inde...delhimodelshub1
 
Russian Call Girls Hyderabad Saloni 9907093804 Independent Escort Service Hyd...
Russian Call Girls Hyderabad Saloni 9907093804 Independent Escort Service Hyd...Russian Call Girls Hyderabad Saloni 9907093804 Independent Escort Service Hyd...
Russian Call Girls Hyderabad Saloni 9907093804 Independent Escort Service Hyd...delhimodelshub1
 
Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service Mohali
Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service MohaliCall Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service Mohali
Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service MohaliHigh Profile Call Girls Chandigarh Aarushi
 
Call Girls Service Chandigarh Gori WhatsApp ❤9115573837 VIP Call Girls Chandi...
Call Girls Service Chandigarh Gori WhatsApp ❤9115573837 VIP Call Girls Chandi...Call Girls Service Chandigarh Gori WhatsApp ❤9115573837 VIP Call Girls Chandi...
Call Girls Service Chandigarh Gori WhatsApp ❤9115573837 VIP Call Girls Chandi...Niamh verma
 
VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591
VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591
VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591adityaroy0215
 
Russian Call Girls in Raipur 9873940964 Book Hot And Sexy Girls
Russian Call Girls in Raipur 9873940964 Book Hot And Sexy GirlsRussian Call Girls in Raipur 9873940964 Book Hot And Sexy Girls
Russian Call Girls in Raipur 9873940964 Book Hot And Sexy Girlsddev2574
 
Vip Kolkata Call Girls Cossipore 👉 8250192130 ❣️💯 Available With Room 24×7
Vip Kolkata Call Girls Cossipore 👉 8250192130 ❣️💯 Available With Room 24×7Vip Kolkata Call Girls Cossipore 👉 8250192130 ❣️💯 Available With Room 24×7
Vip Kolkata Call Girls Cossipore 👉 8250192130 ❣️💯 Available With Room 24×7Miss joya
 
indian Call Girl Panchkula ❤️🍑 9907093804 Low Rate Call Girls Ludhiana Tulsi
indian Call Girl Panchkula ❤️🍑 9907093804 Low Rate Call Girls Ludhiana Tulsiindian Call Girl Panchkula ❤️🍑 9907093804 Low Rate Call Girls Ludhiana Tulsi
indian Call Girl Panchkula ❤️🍑 9907093804 Low Rate Call Girls Ludhiana TulsiHigh Profile Call Girls Chandigarh Aarushi
 
No Advance 9053900678 Chandigarh Call Girls , Indian Call Girls For Full Ni...
No Advance 9053900678 Chandigarh  Call Girls , Indian Call Girls  For Full Ni...No Advance 9053900678 Chandigarh  Call Girls , Indian Call Girls  For Full Ni...
No Advance 9053900678 Chandigarh Call Girls , Indian Call Girls For Full Ni...Vip call girls In Chandigarh
 
Call Girls Secunderabad 7001305949 all area service COD available Any Time
Call Girls Secunderabad 7001305949 all area service COD available Any TimeCall Girls Secunderabad 7001305949 all area service COD available Any Time
Call Girls Secunderabad 7001305949 all area service COD available Any Timedelhimodelshub1
 
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...High Profile Call Girls Chandigarh Aarushi
 
VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591
VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591
VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591adityaroy0215
 
VIP Call Girls Sector 67 Gurgaon Just Call Me 9711199012
VIP Call Girls Sector 67 Gurgaon Just Call Me 9711199012VIP Call Girls Sector 67 Gurgaon Just Call Me 9711199012
VIP Call Girls Sector 67 Gurgaon Just Call Me 9711199012Call Girls Service Gurgaon
 
College Call Girls Hyderabad Sakshi 9907093804 Independent Escort Service Hyd...
College Call Girls Hyderabad Sakshi 9907093804 Independent Escort Service Hyd...College Call Girls Hyderabad Sakshi 9907093804 Independent Escort Service Hyd...
College Call Girls Hyderabad Sakshi 9907093804 Independent Escort Service Hyd...delhimodelshub1
 
VIP Call Girl Sector 32 Noida Just Book Me 9711199171
VIP Call Girl Sector 32 Noida Just Book Me 9711199171VIP Call Girl Sector 32 Noida Just Book Me 9711199171
VIP Call Girl Sector 32 Noida Just Book Me 9711199171Call Girls Service Gurgaon
 
Call Girl Raipur 9873940964 Book Hot And Sexy Girls
Call Girl Raipur 9873940964 Book Hot And Sexy GirlsCall Girl Raipur 9873940964 Book Hot And Sexy Girls
Call Girl Raipur 9873940964 Book Hot And Sexy Girlsddev2574
 

Recently uploaded (20)

Leading transformational change: inner and outer skills
Leading transformational change: inner and outer skillsLeading transformational change: inner and outer skills
Leading transformational change: inner and outer skills
 
hyderabad call girl.pdfRussian Call Girls in Hyderabad Amrita 9907093804 Inde...
hyderabad call girl.pdfRussian Call Girls in Hyderabad Amrita 9907093804 Inde...hyderabad call girl.pdfRussian Call Girls in Hyderabad Amrita 9907093804 Inde...
hyderabad call girl.pdfRussian Call Girls in Hyderabad Amrita 9907093804 Inde...
 
Russian Call Girls Hyderabad Saloni 9907093804 Independent Escort Service Hyd...
Russian Call Girls Hyderabad Saloni 9907093804 Independent Escort Service Hyd...Russian Call Girls Hyderabad Saloni 9907093804 Independent Escort Service Hyd...
Russian Call Girls Hyderabad Saloni 9907093804 Independent Escort Service Hyd...
 
Call Girl Dehradun Aashi 🔝 7001305949 🔝 💃 Independent Escort Service Dehradun
Call Girl Dehradun Aashi 🔝 7001305949 🔝 💃 Independent Escort Service DehradunCall Girl Dehradun Aashi 🔝 7001305949 🔝 💃 Independent Escort Service Dehradun
Call Girl Dehradun Aashi 🔝 7001305949 🔝 💃 Independent Escort Service Dehradun
 
VIP Call Girls Lucknow Isha 🔝 9719455033 🔝 🎶 Independent Escort Service Lucknow
VIP Call Girls Lucknow Isha 🔝 9719455033 🔝 🎶 Independent Escort Service LucknowVIP Call Girls Lucknow Isha 🔝 9719455033 🔝 🎶 Independent Escort Service Lucknow
VIP Call Girls Lucknow Isha 🔝 9719455033 🔝 🎶 Independent Escort Service Lucknow
 
Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service Mohali
Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service MohaliCall Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service Mohali
Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service Mohali
 
Call Girls Service Chandigarh Gori WhatsApp ❤9115573837 VIP Call Girls Chandi...
Call Girls Service Chandigarh Gori WhatsApp ❤9115573837 VIP Call Girls Chandi...Call Girls Service Chandigarh Gori WhatsApp ❤9115573837 VIP Call Girls Chandi...
Call Girls Service Chandigarh Gori WhatsApp ❤9115573837 VIP Call Girls Chandi...
 
Call Girls in Lucknow Esha 🔝 8923113531 🔝 🎶 Independent Escort Service Lucknow
Call Girls in Lucknow Esha 🔝 8923113531  🔝 🎶 Independent Escort Service LucknowCall Girls in Lucknow Esha 🔝 8923113531  🔝 🎶 Independent Escort Service Lucknow
Call Girls in Lucknow Esha 🔝 8923113531 🔝 🎶 Independent Escort Service Lucknow
 
VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591
VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591
VIP Call Girl Sector 25 Gurgaon Just Call Me 9899900591
 
Russian Call Girls in Raipur 9873940964 Book Hot And Sexy Girls
Russian Call Girls in Raipur 9873940964 Book Hot And Sexy GirlsRussian Call Girls in Raipur 9873940964 Book Hot And Sexy Girls
Russian Call Girls in Raipur 9873940964 Book Hot And Sexy Girls
 
Vip Kolkata Call Girls Cossipore 👉 8250192130 ❣️💯 Available With Room 24×7
Vip Kolkata Call Girls Cossipore 👉 8250192130 ❣️💯 Available With Room 24×7Vip Kolkata Call Girls Cossipore 👉 8250192130 ❣️💯 Available With Room 24×7
Vip Kolkata Call Girls Cossipore 👉 8250192130 ❣️💯 Available With Room 24×7
 
indian Call Girl Panchkula ❤️🍑 9907093804 Low Rate Call Girls Ludhiana Tulsi
indian Call Girl Panchkula ❤️🍑 9907093804 Low Rate Call Girls Ludhiana Tulsiindian Call Girl Panchkula ❤️🍑 9907093804 Low Rate Call Girls Ludhiana Tulsi
indian Call Girl Panchkula ❤️🍑 9907093804 Low Rate Call Girls Ludhiana Tulsi
 
No Advance 9053900678 Chandigarh Call Girls , Indian Call Girls For Full Ni...
No Advance 9053900678 Chandigarh  Call Girls , Indian Call Girls  For Full Ni...No Advance 9053900678 Chandigarh  Call Girls , Indian Call Girls  For Full Ni...
No Advance 9053900678 Chandigarh Call Girls , Indian Call Girls For Full Ni...
 
Call Girls Secunderabad 7001305949 all area service COD available Any Time
Call Girls Secunderabad 7001305949 all area service COD available Any TimeCall Girls Secunderabad 7001305949 all area service COD available Any Time
Call Girls Secunderabad 7001305949 all area service COD available Any Time
 
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...
 
VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591
VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591
VIP Call Girl Sector 88 Gurgaon Delhi Just Call Me 9899900591
 
VIP Call Girls Sector 67 Gurgaon Just Call Me 9711199012
VIP Call Girls Sector 67 Gurgaon Just Call Me 9711199012VIP Call Girls Sector 67 Gurgaon Just Call Me 9711199012
VIP Call Girls Sector 67 Gurgaon Just Call Me 9711199012
 
College Call Girls Hyderabad Sakshi 9907093804 Independent Escort Service Hyd...
College Call Girls Hyderabad Sakshi 9907093804 Independent Escort Service Hyd...College Call Girls Hyderabad Sakshi 9907093804 Independent Escort Service Hyd...
College Call Girls Hyderabad Sakshi 9907093804 Independent Escort Service Hyd...
 
VIP Call Girl Sector 32 Noida Just Book Me 9711199171
VIP Call Girl Sector 32 Noida Just Book Me 9711199171VIP Call Girl Sector 32 Noida Just Book Me 9711199171
VIP Call Girl Sector 32 Noida Just Book Me 9711199171
 
Call Girl Raipur 9873940964 Book Hot And Sexy Girls
Call Girl Raipur 9873940964 Book Hot And Sexy GirlsCall Girl Raipur 9873940964 Book Hot And Sexy Girls
Call Girl Raipur 9873940964 Book Hot And Sexy Girls
 

Red Hot Infections in Pregnancy

  • 1. What’s RED & HOT: INFECTIONS in PREGNANCY Helen Madamba, M.D. M.P.H.-T.M. Mitzi Marie M. Chua, M.D. http://www.epid.gov.lk/web/images/pdf/Influenza/Events/pregnant_women.gif
  • 3. Session Objectives To determine the optimum treatment for selected infections commonly seen in pregnancy  UTI  HIV/AIDS  Hepatitis B infection  Human papillomavirus  Syphilis To integrate a management approach based on the current evidence and local applicability
  • 4. “InfectionPackage” forPrenatalCare Routine tests for infections during prenatal care  Urinalysis, urine culture for UTI  HIV Counselling and Testing  HBsAg for Hepatitis B infection  Papsmear for Human papillomavirus  RPR or VDRL for Syphilis
  • 6. Doyouroutinelyorderurine cultureaspartofprenatalcare? Question for our OBs in the audience In ALL pregnant patients, a urine specimen should be carefully collected for urinalysis and culturing during the first prenatal visit or at 12-16 weeks’ (9th- 17th, preferably 16th week) gestation. U.S. Preventive Services Task Force. Screening for asymptomatic bacteriuria in adults- U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2008 Jul 1. 149(1)-43-7. [Medline].
  • 7. Impactof MaternalUTI totheFetus  Uterine hypoperfusion due to maternal dehydration, maternal anemia, and direct bacterial endotoxin damage to the placental vasculature  fetal cerebral hypoperfusion  Untreated upper UTIs associations:  Low birth weight  Prematurity; Premature labor  Hypertension; preeclampsia  Maternal anemia  Amnionitis
  • 8. UA–MSCC  With one hand, spread the labia.  With the other hand, use a castile soap– moistened towelette to wipe the urethral meatus downward toward the rectum, then discard the towelette.  Void the initial portion of the bladder contents into the toilet.  Catch the middle portion of the bladder contents in the sterile collection container, while keeping the labia spread with the first hand. RED-ytocollect?
  • 9. UTI Spectrum: Acute cystitis Asymptomatic bacteriuria (ASB) Acute pyelonephritis Management Pearls Outpatient Oral antibiotics Inpatient, IV antibiotics https://emedicine.medscape.com/article/452604-overview
  • 10. Acute Uncomplicated Cystitis A 27-year old, G1P0 13 weeks’ AOG, had urinary frequency and terminal dysuria for 2 days. There was no fever. There were also no vaginal discharges. WhatUTIcategory?  A 27-year old, G1P0 13 weeks’ AOG, had urinary frequency and terminal dysuria for 2 days. There was no fever. There were also no vaginal discharges. Diagnostics  Urine culture/ sensitivity studies  Significant pyuria (UA)  >8 pus cells/mm3 of uncentrifuged urine, OR  >5 pus cells/HPF of centrifuged urine AND  (+) leukocyte esterase and nitrite test on dipstick Strong recommendation, Moderate quality of evidence
  • 12. Asymptomatic Bacteriuria  A 37-year old G3P2 16 5/7 weeks AOG had a urine culture growth of >100,000 CFU Escherichia coli.  On review of presentation, patient had no complaints but culture was ordered by attending OB after 2 urinalysis samples showed pyuria. WhatUTIcategory?
  • 14. Howwillyou followupthis pregnantpatient withASB? Post-treatment diagnostic tests  A follow-up urine culture should be done one week after completing the course of treatment. Weak recommendation, Low quality of evidence
  • 15. Hot‘n confusing? ANTIBIOTIC SELECTION  If the patient is clinically responding to the present treatment, no need to revise the antibiotic if resistance to the empirically started antibiotic is reported on urine culture. Adjust antibiotic therapy based on urine culture results ONLY when there is no improvement in the clinical signs and symptoms and laboratory results or when there is worsening of the patient’s condition. Strong recommendation, Low quality of evidence MONITORING  Pregnant patients with pyelonephritis, recurrent UTIs, concurrent gestational DM, concurrent nephrolithiasis or urolithiasis, and pre- eclampsia, should be monitored at monthly intervals until delivery to ensure that urine remains sterile during pregnancy. Strong recommendation, Low quality of evidence [NAG] … and monitor every trimester till delivery.
  • 18. Acute Uncomplicated Pyelonephritis A 30-year old, G2P1 12 weeks’ AOG, presented with fever and chills. On PE, she had right costovertebral angle tenderness. WhatUTIcategory?
  • 20. Renal Ultrasound Unless an anatomic abnormality or renal disease is suspected, initial routine imaging studies are not necessary. Patients with suspected pyelonephritis who are not responsive to appropriate antibiotic therapy after 48-72 hours should also undergo imaging. Willyouorder?
  • 21. Acute Uncomplicated Pyelonephritis The same 30-year old, G2P1 now 30 weeks’ AOG, presented with fever, no chills. On PE, she had right costovertebral angle tenderness. Urine culture revealed ESBL Escherichia coli. Referred to ID; patient covered with ertapenem WhatUTIcategory?
  • 22. Prevention Behavioral Methods  Avoid baths.  Wipe front-to-back after urinating or defecating.  Wash hands before using the toilet.  Use washcloths to clean the perineum.  Use liquid soap to prevent colonization from bar soap.  Clean the urethral meatus first when bathing. Thisone’sHOT!
  • 24. A21-yearold, G1P026weeksAOG, (+)historyofIVdruguse,cameback withCBC,U/A,andHBsAgresult. HBsAgscreenisnon-reactive. HIVscreenisreactive. All pregnant patients routinely offered HIV testing. https://www.hepmag.com/basics/hepatitis-b- basics/pregnancy-hepatitis-b
  • 25.  Prong 1. Primary prevention of HIV among women of child-bearing age.  Prong 2. Preventing unintended pregnancies among women living with HIV.  Prong 3. Preventing HIV transmission among women living with HIV to her infant.  Prong 4. Providing treatment, care and support to women living with HIV, their children and their families. https://www.hsph.harvard.edu/population/aids/philippines.aids.09.pdf Preventionof Motherto Child Transmissionof HIVInfection
  • 26. Prong1.Primaryprevention ofHIVamongwomenofchild-bearingage. A – abstinence B – be mutually faithful C – check your status D – don’t inject drugs E – educate yourself and others for early detection Primary Preventionof HIVinfection
  • 27. Prong2. PreventingunintendedpregnanciesamongwomenlivingwithHIV Preventing unplanned pregnancies HIV/AIDS and ART Registry of the Philippines, Department of Health Epidemiology Bureau
  • 29. Preliminary Counselling Dialogue Providers of obstetric care should inform the patient that an HIV screening test will be performed as part of the recommended routine antenatal package of tests of infections (HBsAg, RPR/VDRL, papsmear, urine culture) POGS Clinical Practice Recommendations on PMTCT HIVCounselling andTesting
  • 30. Preliminary Counselling Dialogue The fact that you are pregnant is an evidence of unprotected penetrative sexual contact which is a mode of transmission for HIV. POGS Clinical Practice Recommendations on PMTCT HIVCounselling andTesting
  • 31. AdvantagesofOptionB+ Earlier treatment for woman’s health and avoiding risks of stopping and starting triple ARVs especially in settings of high fertility Simple message to communities “once ARV started, it is taken for life.” POGS Clinical Practice Recommendations on PMTCT Anti-retroviral (ARV)Drugs
  • 32. • An elective cesarean delivery is scheduled at 38 weeks AOG • Emergency CS is done for those in labor and with ruptured membranes <4 hours unless delivery is imminent POGS Clinical Practice Recommendation on PMTCT of HIV Infection. November 2015. Managementof Delivery
  • 33. Vaginal delivery maybe done when the risk of maternal to child transmission is low: • those who had ARV treatment • HIV viral load <1000 copies/ml • if with ruptured membranes, the time elapsed should be <4 hours to delivery POGS Clinical Practice Recommendation on PMTCT of HIV Infection. November 2015. Managementof Delivery
  • 34. INFORMED CONSENT NO MIXED FEEDING EXCLUSIVE breastfeeding or AFASS replacement feeding InfantFeeding REDHOTFEEDING!
  • 35. initiate/continue ARV medications replacement feeding: acceptable, feasible, affordable, sustainable and safe (AFASS) risks, follow up and other options for replacement feeding relieve breast engorgement POGS Clinical Practice Recommendations on PMTCT InfantFeeding REDHOTFEEDING!
  • 36. A24-yearold, G7P7(7007) 3days postpartum,breastfeedinginthe ward. MHOcallstoinformthat patientistheirprenatalclient. HIVscreenisreactive. REDHOTSURPRISE! https://www.hepmag.com/basics/hepatitis-b- basics/pregnancy-hepatitis-b
  • 37. Continue exclusive breastfeeding Initiate/continue ARV medications for both mother and patient for as long as breastfeeding up to two (2) years POGS Clinical Practice Recommendations on PMTCT InfantFeeding REDHOTFEEDING!
  • 38. Prong4. Providingtreatment,care andsupporttowomenlivingwithHIV, theirchildrenandtheirfamilies. Sexualand reproductive healthand rights(SRHR) Framework of WHO recommendations and good practice statements to advance the sexual and reproductive health and rights of women living with HIV
  • 39. Life goes on beyondHIV Anti-retroviral (ARV)Drugs
  • 41. A19-year old, G1P016weeks pregnant, camebackwithCBC, U/A,and HBsAgresult. HBsAgscreenisreactive. HBs Ag screen seems always done. https://www.hepmag.com/basics/hepatitis-b- basics/pregnancy-hepatitis-b
  • 42. Whatdoyou do? Additional testing (ALT, HBV DNA, or imaging for HCC surveillance if indicated) Determination of need for antiviral therapy Women who meet standard indications for HBV therapy should be treated.
  • 43. Getaviralload! Pregnant women positive for HBsAg should be tested for hep B virus deoxyribonucleic acid (HBV DNA) to guide the use of antiviral medication to prevent perinatal transmission. Red-hotCOST!
  • 44. Individualize therapytoreduce theriskof perinatal transmission. The American Association for the Study of Liver Diseases (AASLD) suggests antiviral therapy for pregnant women with HBV DNA >200,000 IU/mL. Quality and Certainty of Evidence: Low Strength of Recommendation: Conditional
  • 45. Theironyof“strengthof recommendation” AASLD recommends against the use of antiviral therapy to reduce the risk of perinatal transmission of HBV in HBsAg-positive pregnant women with an HBV- DNA level <200,000 IU/mL. Quality and Certainty of Evidence: Low Strength of Recommendation: Strong
  • 46. Whatto give? The only antivirals studied in pregnant women are lamivudine, telbivudine, and tenofovir (TDF). TDF preferred to minimize the risk of emergence of viral resistance during treatment Red-hotchoices
  • 47. Timing& Duration Antiviral therapy started at 28-32 weeks’ gestation in most studies. Discontinued at time of delivery or up to 4 weeks postpartum  At time of birth to 3 months postpartum in most studies With discontinuation of treatment, women should be monitored closely for up to 6 months after delivery for hepatitis flares & seroconversion.
  • 48. Immune-active hepatitis  Elevation of ALT >2 the ULN or evidence of significant histologic disease  ULN for ALT in healthy adults is reported to be 29-33 U/L for males and 19-25 U/L for females. A ULN for ALT of 35 U/L for males and 25 U/L for females is recommended to guide management decisions. PLUS  Elevated HBV DNA above 2,000 IU/mL (HBeAg negative) or above 20,000 IU/mL (HBeAg positive).  Treatment should be based on recommendations for nonpregnant women. Butdonotethat–
  • 49. Breastfeeding NOT contraindicated Antivirals minimally excreted in breast milk &unlikely to cause significant toxicity Insufficient long-term safety data in infants born to mothers who took antiviral agents during pregnancy and while breastfeeding HotOtherMatters
  • 50. Wedon’tmiss this,dowe? The CDC continues to recommend hepatitis B vaccination and hepatitis immune globulin regardless of birth weight within 12 hours of birth for infants born to hepatitis B-infected mothers. Red-hotINTERVENTION
  • 51. Doyouroutinelyvaccinate pregnantwomenaspartof prenatalcare? Question for our OBs in the audience • Tetanus- diphtheria- pertussis • Influenza vaccine • Pneumococcal vaccine • Hepatitis B POGS Clinical Practice Guidelines on Immunization for Filipino Women 2011
  • 52. Whichvaccinesare contraindicatedinpregnancy? Live attenuated vaccines are contraindicated in pregnancy. • HPV vaccine • Varicella zoster • Measles, mumps and rubella POGS Clinical Practice Guidelines on Immunization for Filipino Women 2011
  • 53. Tetanus-diphtheria-pertussis (Tdap)vaccine No previous tetanus immunization of unknown status: • 3 doses of Td vaccine given one month apart, starting second trimester • 3rd dose given postpartum as Tdap Level 1 Grade A POGS Clinical Practice Guidelines on Immunization for Filipino Women 2011
  • 54. Tetanus-diphtheria-pertussis (Tdap)vaccine Last Td/Tdap vaccination more than 10 years ago: • Td booster in second or 3rd trimester of pregnancy Level 1 Grade A POGS Clinical Practice Guidelines on Immunization for Filipino Women 2011
  • 55. Influenzavaccine All pregnant and breastfeeding women should receive the inactivated flu vaccine (Level I, Grade A) POGS Clinical Practice Guidelines on Immunization for Filipino Women 2011
  • 56. Pneumococcalvaccine Pneumococcal vaccination should be recommended to pregnant and breastfeeding women who are at high-risk for invasive pneumococcal disease. POGS Clinical Practice Guidelines on Immunization for Filipino Women 2011
  • 57. Pneumococcalvaccine Pneumococcal vaccination should preferably be administered during the 2nd or 3rd trimester of pregnancy as a general safety precaution. POGS Clinical Practice Guidelines on Immunization for Filipino Women 2011
  • 58. HepatitisBvaccine • Hepatitis B vaccine may be administered to a pregnant women who is otherwise eligible for it. • HBsAg-negative pregnant women not previously vaccinated POGS Clinical Practice Guidelines on Immunization for Filipino Women 2011
  • 60. HPV screening  In 2003, the FDA approved a screening test that can be done in conjunction with a Pap test to determine if you have the HPV virus. The HPV DNA test can detect high risk types of HPV, such as types 16 and 18, before any abnormal cells can be detected on the cervix.  This screening is recommended for women over the age of 30, who are at an increased risk of a chronic HPV infection turning into pre-cancerous cells.  Men can carry and transmit the HPV infection without ever having symptoms. At this time, there is no test to detect HPV in men.
  • 61. 36year oldelderly primigravid consults forprenatal checkup complaining ofcauliflower-like massesonthevulva. HPV causes genital warts. https://www.hepmag.com/basics/hepatitis-b- basics/pregnancy-hepatitis-b
  • 62. HPV Infection ~100 types of HPV infection, 40 can infect genital area Most sexually active persons become infected with HPV at leat once in their lifetime. Red-hotMYSTERIES
  • 63. HPV Infection Oncogenic, high-risk HPV infection causes most cervical, penile, vulvar, vaginal, anal and oropharyngeal cancers and pre-cancers Non-oncogenic low-risk HPV infection causes genital warts and recurrent respiratory papillomatosis Red-hotMYSTERIES CDC Sexually Transmitted Diseases Guidelines, 2015
  • 64. KeyMessages forCounselling Most sexually active people get HPV at some time in their lives, although most never know it. It is not possible to determine which partner transmitted the original infection. Types of HPV that cause genital warts are different from the types that cause cancer. Red-hotMESSAGES CDC Sexually Transmitted Diseases Guidelines, 2015
  • 65. Special Considerations Podofilox, podophyllin, sinecatechins, imiquimod should not be used in pregnancy Anogenital warts can proliferate and become friable during pregnancy Resolution might be incomplete or poor until pregnancy is complete. Red-hotMESSAGES CDC Sexually Transmitted Diseases Guidelines, 2015
  • 66. Managementof Delivery Cesarean delivery should not be performed solely to prevent transmission of HPV infection to the newborn Cesarean delivery is indicated if pelvic outlet is obstructed or if vaginal delivery would result in excessive bleeding. Low risk for recurrent respiratory papillomatosis CDC Sexually Transmitted Diseases Guidelines, 2015
  • 67. Doyouroutinelyscreenfor HPVaspartofprenatalcare? Question for our OBs in the audience Cervical cancer screening should be part of routine prenatal care. • Papsmear • Visual inspection with acetic acid (VIA) • HPV testing Society of Gynecologic Oncologists of the Philippines (Foundation) Inc. Clinical Practice Guidelines for the Obstetrician-Gynecologist 2010
  • 68. Doyouroutinelyscreenfor HPVaspartofprenatalcare? Question for our OBs in the audience Cervical cancer screening should be part of routine prenatal care. • Papsmear • Visual inspection with acetic acid (VIA) • HPV testing Society of Gynecologic Oncologists of the Philippines (Foundation) Inc. Clinical Practice Guidelines for the Obstetrician-Gynecologist 2010
  • 69. AmIatriskfor cervicalcancer?  HPV infection is the necessary cause of cervical cancer.  Parity of 7 or more  Long-term use of OCPs  Smoking  Co-infection of HPV with Chlamydia trachomatis or herpes simplex virus  HIV infection REDflags-risks Society of Gynecologic Oncologists of the Philippines (Foundation) Inc. Clinical Practice Guidelines for the Obstetrician-Gynecologist 2010
  • 70. AmIatriskfor cervicalcancer?  Early age at first intercourse  Lifetime number of sexual partners  Early age at first full term pregnancy  Uncircumcised male partner  No prior screening  Low socioeconomic status REDflags-risks Society of Gynecologic Oncologists of the Philippines (Foundation) Inc. Clinical Practice Guidelines for the Obstetrician-Gynecologist 2010
  • 71. Primary Preventionof cervicalcancer  Total abstinence prevents HPV infection.  Lifetime mutual monogamy prevents HPV infection.  Consistent and correct use of barrier protection decreases cervical cancer incidence.  Vaccination against HPV 16/18 is efficacious against persistent HPV infection and ≥ CIN 2+. REDHOTINTERVENTION Society of Gynecologic Oncologists of the Philippines (Foundation) Inc. Clinical Practice Guidelines for the Obstetrician-Gynecologist 2010
  • 72. Secondary Preventionof cervicalcancer  Regular gynecologic examinations and cytologic test (Pap smear) with treatment of precancerous abnormalities  Liquid based cytology  Visual inspection with acetic acid is an acceptable alternative to Pap smear. REDHOTINTERVENTION Society of Gynecologic Oncologists of the Philippines (Foundation) Inc. Clinical Practice Guidelines for the Obstetrician-Gynecologist 2010
  • 73. Secondary Preventionof cervicalcancer  Screening should begin approximately 3 years after onset of vaginal intercourse but not earlier than 21.  Annual screening with conventional cervical cytology until age 30 years.  At or after age 30 years, a woman who has had 3 consecutive normal results may undergo screening ever 2 to 3 years REDHOTINTERVENTION Society of Gynecologic Oncologists of the Philippines (Foundation) Inc. Clinical Practice Guidelines for the Obstetrician-Gynecologist 2010
  • 74. Secondary Preventionof cervicalcancer  Annual gynecologic examination is recommended regardless of the frequency of screening.  Women immunized against HPV 16/18 should be screened same as non- immunized women.  A pap test should be obtained twice in the first year after diagnosis of HIV infection and if results are normal, annually thereafter. REDHOTINTERVENTION Society of Gynecologic Oncologists of the Philippines (Foundation) Inc. Clinical Practice Guidelines for the Obstetrician-Gynecologist 2010
  • 75.  In 2003, the FDA approved a screening test that can be done in conjunction with a Pap test to determine if you have the HPV virus. The HPV DNA test can detect high risk types of HPV, such as types 16 and 18, before any abnormal cells can be detected on the cervix.  This screening is recommended for women over the age of 30, who are at an increased risk of a chronic HPV infection turning into pre-cancerous cells.  Men can carry and transmit the HPV infection without ever having symptoms. At this time, there is no test to detect HPV in men.
  • 77. Doyouroutinelyordersyphilis screenaspartofprenatalcare? Question for our OBs in the audience All pregnant women should be screened for syphilis early in pregnancy. CDC Sexually Transmitted Diseases Guidelines, 2015
  • 78. 20year oldG2P1 complained of vulvar ulcers RPRreactive TPPApositive
  • 79. Syphilis Infection Primary syphilis infection – ulcers or chancre at the infection site Secondary syphilis – skin rash, mucocutaneous lesions, lymphadenopathy Tertiary syphilis – cardiac, gummatous lesions, tabes dorsalis, general paresis Latent syphilis infection – those lacking manifestations, detected by serologic testing  Early latent syphilis – acquired within the preceding year  Late latent syphilis – acquired more than a year prior  Syphilis of unknown duration
  • 80. DiagnosticTests forSyphilis Darkfield examination from lesion exudates  definitive method for diagnosing Treponema pallidum A presumptive diagnosis of syphilis requires use of two tests: Nontreponemal test like VDRL or RPR Treponemal test like FTA-ABS, TP-PA, TP-EIA or rapid treponemal assays
  • 81. SyphilisScreening • For patients with poor prenatal care, RPR test screening and treatment should be performed at the time pregnancy is confirmed • Pregnant women with reactive treponemal screening tests should have additional quantitative nontreponemal testing to monitor treatment response. • For women at high risk of infection, serologic testing should be performed twice, at 28-32 weeks AOG and at delivery • Any woman with fetal death after 20 weeks AOG should be tested for syphilis.
  • 82. Syphilisduring Pregnancy Risk for antepartum fetal infection or congenital syphilis at delivery is related to the stage of syphilis during pregnancy, with the highest risk occurring with the primary and secondary stage. Quantitative maternal nontreponemal titer, especially if >1:8, might be a marker of early infection and bacteremia.
  • 83. SyphilisScreening •If a treponemal test (e.g., EIA or CIA) is used for antepartum syphilis screening, all positive EIA/CIA tests should be reflexed to a quantitative nontreponemal test (RPR or VDRL). •If the nontreponemal test is negative, then the results are considered discrepant and a second treponemal test (TP-PA preferred) should be performed, preferably on the same specimen. •If the second treponemal test is positive, current or past syphilis infection can be confirmed.
  • 84. SyphilisScreening •If the second treponemal test is negative, the positive EIA/CIA is more likely to represent a false-positive test result in low-risk women with no history of treated syphilis. •If the woman is at low risk for syphilis, (-) signs or symptoms, partner (-) syphilis, and is likely to follow up, repeat serologic testing within 4 weeks. •If both the RPR and TP-PA remain negative, no further treatment is necessary. •If follow-up is not possible, women without a history of treated syphilis should be treated according to the stage of syphilis.
  • 85. Preferred Regimen Penicillin is the only drug recommended for treatment of pregnant women with syphilis.  Pregnant women allergic to penicillin should be desensitized and treated with penicillin.  Primary, Secondary, Early Latent (<1 year duration)  1st line: Benzathine penicillin G 2.4MU IM x 1 dose  Late latent (including unknown duration)  1st line: Benzathine penicillin G 7.2 MU total, administered as 3 doses of 2.4 MU IM each buttock at 1-week intervals
  • 86. Management Pearls  When syphilis is diagnosed during the second half of pregnancy  Include a sonographic fetal evaluation for congenital syphilis  Sonographic signs of fetal or placental syphilis (i.e., hepatomegaly, ascites, hydrops, fetal anemia, or a thickened placenta) indicate a greater risk for fetal treatment failure  Women treated for syphilis during the second half of pregnancy are at risk for premature labor and/or fetal distress if the treatment precipitates the Jarisch-Herxheimer reaction.  Advise to seek obstetric attention after treatment if they notice any fever, contractions, or decrease in fetal movements.
  • 87. Missed doses are not acceptable for pregnant women receiving therapy for late latent syphilis. Pregnant women who miss any dose of therapy must repeat the full course of therapy. All women who have syphilis should be offered testing for HIV infection. Management Pearls

Editor's Notes

  1. U.S. Preventive Services Task Force. Screening for asymptomatic bacteriuria in adults- U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2008 Jul 1. 149(1)-43-7. [Medline].
  2. Maternal UTI has few direct fetal sequelae because fetal bloodstream infection is rare; however, uterine hypoperfusion due to maternal dehydration, maternal anemia, and direct bacterial endotoxin damage to the placental vasculature may cause fetal cerebral hypoperfusion. Untreated upper UTIs are associated with low birth weight, prematurity, premature labor, hypertension, preeclampsia, maternal anemia, and amnionitis. [12] A retrospective population-based study by Mazor-Dray et al showed that UTI during pregnancy is independently associated with intrauterine growth restriction, preeclampsia, preterm delivery, and cesarean delivery. [9] A prospective cohort study of pregnant patients also suggested an association between maternal UTI and childhood asthma. [13]
  3. Millar and Cox indicate that 1-2 bacteria in an unspun catheterized specimen or more than 20 bacteria per high-power field (HPF) in spun urine correlate closely with bacterial colony counts higher than 100,000 CFU/mL on a urine culture. [18]
  4. Hormonal and mechanical changes can promote urinary stasis and vesicoureteral reflux. These changes, along with an already short urethra (approximately 3-4 cm in females) and difficulty with hygiene due to a distended pregnant belly, help make UTIs among the most common bacterial infections during pregnancy. In general, pregnant patients are considered immunocompromised UTI hosts because of the physiologic changes associated with pregnancy (see Pathophysiology). 
  5. Acute cystitis is complicated by upper urinary tract disease (ie, pyelonephritis) in 15-50% of cases.
  6. NAG: Start empiric antibiotic immediately, but pre-treatment urine must be submitted for culture and susceptibility; adjust treatment accordingly. Document clearance of bacteriuria with a repeat urine culture 1-2 weeks post-treatment. Avoid amoxicillin-clavulanate in those at risk of pre-term labor because of potential for neonatal necrotizing enterocolitis. Use nitrofurantoin from the 2nd trimester to 32 weeks only, if possible, because of potential for birth defects and hemolytic anemia. Avoid cotrimoxazole especially during the first and third trimesters because of risk of teratogenicity and kernicterus. Fluoroquinolones are contraindicated.
  7. Untreated asymptomatic bacteriuria is a risk factor for acute cystitis (40%) and pyelonephritis (25-30%) in pregnancy. These cases account for 70% of all cases of symptomatic UTI in unscreened pregnant women. A difference between pregnant and nonpregnant women is that the prevalence of asymptomatic bacteriuria in pregnant women is 2.5-11%, as opposed to 3-8% in nonpregnant women. In as many as 40% of these cases, bacteriuria may progress to symptomatic upper UTI or pyelonephritis; this rate is significantly higher than that seen in nonpregnant women. [4]
  8. Cephalexin 500 mg 4 times daily Ampicillin 500 mg 4 times daily Nitrofurantoin 100 mg twice daily Sulfisoxazole 1 g 4 times daily Nitrofurantoin monohydrate/macrocrystals 100 mg orally twice daily for 5-7 days or Amoxicillin 500 mg orally twice daily (alternative: 250 mg orally three times daily) for 5-7 days or Amoxicillin-clavulanate 500/125 mg orally twice daily for 3-7 days (alternative: 250/125 mg orally three times daily for 5-7 days) or Cephalexin 500 mg orally twice daily for 3-7 days
  9. A test-for-cure urine culture should show negative findings 1-2 weeks after therapy. A nonnegative culture result is an indication for a 10- to 14-day course of a different antibiotic, followed by suppressive therapy (eg, nitrofurantoin 50 mg at bedtime) until 6 weeks postpartum.
  10. Fluoroquinolones are to be used with caution in pregnancy. Both ciprofloxacin and levofloxacin have been assigned pregnancy category C by the FDA (fetal risk is not confirmed by human studies but has been shown in some animal studies). Although not a first-line option for treatment of UTI in pregnancy, in certain clinical situations the benefits of using a fluoroquinolone may outweigh the risks to the developing fetus.
  11. Nitrofurantoin is safe and effective; however, poor tissue penetration has limited its use in pyelonephritis. In the past, nitrofurantoin was completely avoided in the third trimester because of hemolytic effects on the newborn. Currently, restriction of this agent is limited to the last several weeks of pregnancy. Use during this period can cause hemolytic anemia in the fetus or neonate as a consequence of their immature erythrocyte enzyme systems (glutathione instability). Nitrofurantoin is also safe and effective for once-daily prophylactic therapy during pregnancy. [25] Tetracyclines (adverse effects on fetal teeth and bones and congenital defects) Trimethoprim in the first trimester (facial defects and cardiac abnormalities) Chloramphenicol (gray syndrome) Sulfonamides in the third trimester (hemolytic anemia in mothers with glucose-6-phosphate dehydrogenase [G6PD] deficiency, jaundice, and kernicterus)
  12. Cesarean delivery is associated with UTI (increasing the likelihood 2.7-fold), but this association may be confounded by bladder catheterization or prolonged rupture of membranes (PROM). The incidence of symptomatic UTI is 9.3%, and that of asymptomatic bacteriuria is 7.6%. Patients with pyelonephritis have fever (usually >38°C), flank tenderness upon palpation, and an ill appearance. Flank tenderness occurs on the right side in more than half of patients, bilaterally in one fourth, and on the left side in one fourth. Pain may also be found suprapubically with palpation.
  13. Urinalysis, gram stain and culture/susceptibility tests should be done. Blood cultures are not routinely done unless septic. Ultrasound of KUB reserved for failure to respond to treatment. Indications for admission: pre-term labor and other indications as listed above for acute uncomplicated pyelonephritis. Switch to oral regimen when afebrile x 48 hrs. and based on culture/susceptibility result. Recommended duration of treatment is 14d. Test of cure with a urine culture post-treatment is essential. Follow up with monthly urine culture until delivery.
  14. Cesarean delivery is associated with UTI (increasing the likelihood 2.7-fold), but this association may be confounded by bladder catheterization or prolonged rupture of membranes (PROM). The incidence of symptomatic UTI is 9.3%, and that of asymptomatic bacteriuria is 7.6%. Patients with pyelonephritis have fever (usually >38°C), flank tenderness upon palpation, and an ill appearance. Flank tenderness occurs on the right side in more than half of patients, bilaterally in one fourth, and on the left side in one fourth. Pain may also be found suprapubically with palpation.
  15. to ensure good hygiene and reduce bacterial contamination of the urethral meatus, thereby preventing inadequate treatment and recurrent infection
  16. Down to the
  17. In addition to receiving ARVs, all HIV positive pregnant women are scheduled for an elective CS. The POGS clinical guidelines on HIV recommends cesarean delivery at completed 38 weeks age of gestation. If there is spontaneous rupture of amniotic bag of less than 4 hours, perform an emergency cesarean section, unless delivery is imminent. A longer duration of ruptured membranes may be associated with a higher rate of mother-to-child transmission risk of vertical transmission increased by 2% for every increase of 1 hour in the duration of ruptured membranes (International Perinatal HIV group meta-analysis)
  18. Vaginal delivery may be performed when the risk of mother-to-child transmission of HIV is low as in the following situations: In those who received anti-HIV medications during pregnancy and have a viral load less than 1,000 copies/mL near the time of delivery and if membranes rupture, the time elapsed should not be more than 4 hours to delivery.
  19. Down to the
  20. Engage in talk with Helen Is HBsAg done twice- on first PNC and then at time of admission … routinely? HBsAg reactive  what is usual course of action (i.e. get quantitative HBs Ag, get panel, refer to Gastro or ID?)
  21. The CDC and ACIP’s updated guidance reflects the best currently available evidence and select new or updated recommendations Published evidence indicates that maternal antiviral therapy during pregnancy further reduces perinatal HBV transmission (2,3,4,5) This Practice Advisory was developed by the American College of Obstetricians and Gynecologists’ Immunization and Emerging Infections Expert Work Group in collaboration with Brenna L. Hughes, MD. In addition to those highlighted above, there are also new recommendations regarding postvaccination serologic testing of infants born to HBsAg-positive mothers and revaccination for those not responding to initial vaccination (see CDC’s MMWR for details). 
  22. The CDC and ACIP’s updated guidance reflects the best currently available evidence and select new or updated recommendations Published evidence indicates that maternal antiviral therapy during pregnancy further reduces perinatal HBV transmission (2,3,4,5) This Practice Advisory was developed by the American College of Obstetricians and Gynecologists’ Immunization and Emerging Infections Expert Work Group in collaboration with Brenna L. Hughes, MD. In addition to those highlighted above, there are also new recommendations regarding postvaccination serologic testing of infants born to HBsAg-positive mothers and revaccination for those not responding to initial vaccination (see CDC’s MMWR for details). 
  23. TDF is the preferred choice owing to its antiviral potency and concerns for resis- tance with the other antiviral agents.
  24. With discontinuation of treatment, women should be monitored for ALT flares every 3 months for 6 months. Interim studies show high efficacy of TDF in preventing mother-to-child transmission. Guidance: TAF has not been studied in pregnant women and no data have been reported to the anti-retroviral registry regarding the safety of TAF in pregnancy. Thus, there are insufficient data to recommend use of TAF in pregnancy.
  25. tenofovir alafenamide (TAF) tenofovir disoproxil fumarate (TDF)
  26. tenofovir alafenamide (TAF) tenofovir disoproxil fumarate (TDF)
  27. The CDC and ACIP’s updated guidance reflects the best currently available evidence and select new or updated recommendations Published evidence indicates that maternal antiviral therapy during pregnancy further reduces perinatal HBV transmission (2,3,4,5) This Practice Advisory was developed by the American College of Obstetricians and Gynecologists’ Immunization and Emerging Infections Expert Work Group in collaboration with Brenna L. Hughes, MD. In addition to those highlighted above, there are also new recommendations regarding postvaccination serologic testing of infants born to HBsAg-positive mothers and revaccination for those not responding to initial vaccination (see CDC’s MMWR for details). 
  28. Hepatitis B vaccine is administered IM in 3 doses at 0,1,6-12 months. The accelerated schedule should be given in 4 doses at 0,1, 2, 12 months. The rapid schedule should be given in 4 doses at 0, 7, 21 days and 12 months.
  29. Most persons who acquire HPV clear the infection spontaneously and have no associated health problems. When the HPV infection does not clear, genital warts, precancers, and cancers of the cervix, anus, penis, vulva, vagina, head and neck might develop.
  30. Most persons who acquire HPV clear the infection spontaneously and have no associated health problems. When the HPV infection does not clear, genital warts, precancers, and cancers of the cervix, anus, penis, vulva, vagina, head and neck might develop.
  31. Lifetime number of sexual partners ≥6
  32. Lifetime number of sexual partners ≥6 First full term pregnancy ≤17 years
  33. All pregnant women should be screened for syphilis early in pregnancy. U.S. Preventive Services Task Force. Screening for asymptomatic bacteriuria in adults- U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2008 Jul 1. 149(1)-43-7. [Medline].
  34. Give the same dose as in non-pregnant women appropriate for the stage of syphilis.
  35. Some evidence suggests that additional therapy is beneficial for pregnant women. For women who have primary, secondary, or early latent syphilis, a second dose of benzathine penicillin 2.4 million units IM can be administered 1 week after the initial dose. No data are available to suggest that corticosteroid treatment alters the risk for treatment-related complications in pregnancy.
  36. Tetracycline and doxycycline are contraindicated in the second and third trimester of pregnancy (317). Erythromycin and azithromycin should not be used, because neither reliably cures maternal infection or treats an infected fetus (444). Data are insufficient to recommend ceftriaxone for treatment of maternal infection and prevention of congenital syphilis.